TI
NBIX icon

Tidal Investments’s Neurocrine Biosciences NBIX Stock Holding History

Tidal Investments’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.7M Buy
81,460
+53,045
+187% +$7.87M 0.02% 574
2026
Q1 		$3.69M Buy
28,415
+17,070
+150% +$2.26M 0.01% 926
2025
Q4 		$1.61M Buy
11,345
+3,612
+47% +$523K ﹤0.01% 1040
2025
Q3 		$1.09M Sell
7,733
-594
-7% -$80.5K ﹤0.01% 1179
2025
Q2 		$1.05M Sell
8,327
-3,760
-31% -$431K 0.01% 1017
2025
Q1 		$1.34M Buy
12,087
+2,662
+28% +$337K 0.01% 856
2024
Q4 		$1.29M Sell
9,425
-5,618
-37% -$695K 0.01% 886
2024
Q3 		$1.73M Buy
15,043
+5,197
+53% +$712K 0.02% 733
2024
Q2 		$1.36M Buy
9,846
+304
+3% +$41.7K 0.02% 742
2024
Q1 		$1.32M Buy
9,542
+3,497
+58% +$478K 0.02% 756
2023
Q4 		$796K Buy
6,045
+3,940
+187% +$454K 0.02% 737
2023
Q3 		$237K Buy
+2,105
New +$222K 0.01% 1148
2023
Q2 		– Sell
-2,057
Closed -$208K – 1361
2023
Q1 		$208K Buy
+2,057
New +$214K 0.01% 1178
2022
Q2 		– Sell
-3,144
Closed -$295K – 1157
2022
Q1 		$295K Buy
3,144
+402
+15% +$34.1K 0.01% 824
2021
Q4 		$234K Buy
2,742
+490
+22% +$45.1K 0.01% 849
2021
Q3 		$216K Buy
+2,252
New +$213K 0.01% 769
2021
Q2 		– Sell
-2,579
Closed -$251K – 739
2021
Q1 		$251K Buy
+2,579
New +$270K 0.01% 478
2020
Q3 		– Sell
-2,246
Closed -$274K – 295
2020
Q2 		$274K Buy
+2,246
New +$248K 0.04% 239

Other funds holding NBIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Tidal Investments's NBIX Position: Q2 2026 in Review

Tidal Investments increased its Neurocrine Biosciences (NBIX) stake by 187% in Q2 2026, buying an estimated $7.87M and bringing the position to 81,460 shares worth $13.7M. The position accounts for 0.02% of the portfolio, ranked #574.

Tidal Investments first reported a position in NBIX in Q2 2020 and has held it in 18 quarters since. 779 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • Tidal Investments held 81,460 shares of Neurocrine Biosciences worth $13.7M as of Q2 2026.
  • Tidal Investments bought 53,045 Neurocrine Biosciences shares in Q2 2026, an estimated $7.87M.
  • Neurocrine Biosciences made up 0.02% of Tidal Investments's portfolio in Q2 2026, its #574 holding.
  • Tidal Investments first reported a position in Neurocrine Biosciences in Q2 2020 and has held it in 18 quarters since.
  • 779 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.